Table S3. Comparison of clinicopathological variables between patients consulting for altered mammograms and those with signs or symptoms of BC.
| N: 1,754 patients | Mammograms (N: 648) | Signs or symptoms (N: 1,106) | p-value |
|---|---|---|---|
| Age at diagnosis, average ± SD | 56.5 ± 10.6 years | 54.5 ± 14.8 years | 0.002 |
| Tumor stage at diagnosis | N, (%) | ||
| Stage I | 363 (58.5%) | 181 (17.5%) | <0.0001 |
| Stage II | 197 (31.8%) | 470 (45.3%) | |
| Stage III | 49 (7.9%) | 308 (29.7%) | |
| Stage IV | 11 (1.8%) | 78 (7.5%) | |
| BC tumor subtype | N, (%) | ||
| Luminal A | 355 (62.9%) | 368 (38.6%) | <0.0001 |
| Luminal B | 133 (23.6%) | 350 (36.7%) | |
| HER2-enriched | 27 (4.8%) | 73 (7.7%) | |
| Triple Negative | 49 (8.7%) | 163 (17.1%) |